최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Hybridoma : journal of molecular immunology and experimental and clinical immunotherapy, v.27 no.1, 2008년, pp.18 - 24
Lee, Myung-Shin (Department of Microbiology and Immunology, Eulji University School of Medicine, Daejeon, South Korea.) , Lee, Ji Chul (Interdisciplinary Program of Biochemical Engineering and Biotechnology, Seoul National University, Seoul, South Korea.) , Choi, Cha Yong (Interdisciplinary Program of Biochemical Engineering and Biotechnology, Seoul National University, Seoul, South Korea.) , Chung, Junho (Department of Biochemistry and Molecular Biology and Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea.)
A monoclonal antibody to the light chain of botulinum neurotoxin type B (BoNT/B) was generated and its protective activity was evaluated in vivo. A chimeric rabbit/human Fab library was generated using bone marrow and spleen cDNAs of rabbits immunized with the BoNT/B light chain, and three monoclona...
Microbiol Rev Gill DM 86 46 1982 10.1128/mr.46.1.86-94.1982
Pearce, L.Bruce, First, Eric R, Maccallum, Robert D, Gupta, Amit. Pharmacologic characterization of Botulinum toxin for basic science and medicine. Toxicon, vol.35, no.9, 1373-1412.
Singh, Bal Ram, Lopes, Teresa, Silvia, Melissa A.. Immunochemical characterization of type a botulinum neurotoxin in its purified and complexed forms. Toxicon, vol.34, no.2, 267-275.
Arnon, S S, Schechter, R, Inglesby, T V, Henderson, D A, Bartlett, J G, Ascher, M S, Eitzen, E, Fine, A D, Hauer, J, Layton, M, Lillibridge, S, Osterholm, M T, O'Toole, T, Parker, G, Perl, T M, Russell, P K, Swerdlow, D L, Tonat, K. Botulinum toxin as a biological weapon: medical and public health management.. JAMA : the journal of the American Medical Association, vol.285, no.8, 1059-1070.
Smith, T. J., Lou, J., Geren, I. N., Forsyth, C. M., Tsai, R., LaPorte, S. L., Tepp, W. H., Bradshaw, M., Johnson, E. A., Smith, L. A., Marks, J. D.. Sequence Variation within Botulinum Neurotoxin Serotypes Impacts Antibody Binding and Neutralization. Infection and immunity, vol.73, no.9, 5450-5457.
Marks, James D.. Deciphering antibody properties that lead to potent botulinum neurotoxin neutralization. Movement disorders : official journal of the Movement Disorder Society, vol.19, no.suppl8, S101-S108.
Mowry, Mark C., Meagher, Mike, Smith, Leonard, Marks, Jim, Subramanian, Anu. Production and purification of a chimeric monoclonal antibody against botulinum neurotoxin serotype A. Protein expression and purification, vol.37, no.2, 399-408.
Mah, David C.W., Hu, Wei-Gang, Pon, J. Kelly, Masri, Saad A., Fulton, R. Elaine, Monette, Paul L., Nagata, Les P.. Recombinant Anti-Botulinum Neurotoxin A Single-Chain Variable Fragment Antibody Generated Using a Phage Display System. Hybridoma and hybridomics, vol.22, no.5, 277-283.
Wu, Han-Chung, Yeh, Chia-Tsui, Huang, Yue-Ling, Tarn, Lih-Jeng, Lung, Chien-Cheng. Characterization of Neutralizing Antibodies and Identification of Neutralizing Epitope Mimics on theClostridium botulinumNeurotoxin Type A. Applied and environmental microbiology, vol.67, no.7, 3201-3207.
Clements, J. D., Pless, Dorothy D., Torres, Edna R., Reinke, Emily K., Bavari, Sina. High-Affinity, Protective Antibodies to the Binding Domain of Botulinum Neurotoxin Type A. Infection and immunity, vol.69, no.1, 570-574.
Methods Mol Biol Amersdorfer P 219 145 2000
DI BELLO, Isabelle CENCI, POULAIN, Bernard, SHONE, Clifford C., TAUC, Ladislav, DOLLY, J. Oliver. Antagonism of the intracellular action of botulinum neurotoxin type A with monoclonal antibodies that map to light‐chain epitopes. European journal of biochemistry, vol.219, no.1, 161-169.
Ferreira, Jospeh L., Hamdy, Mostafa K., Herd, Zana L., McCay, Steven G., Zapatka, Francis A.. Monoclonal antibody for the detection of Clostridium botulinum type A toxin. Molecular and cellular probes, vol.1, no.4, 337-345.
Yang, Gi-Hyeok, Kim, Kyu-Sik, Kim, Hak-Woo, Jeong, Sung Tae, Huh, Gyung Heng, Kim, Ji Cheon, Jung, Hyun Ho. Isolation and characterization of a neutralizing antibody specific to internalization domain of Clostridium botulinum neurotoxin type B. Toxicon, vol.44, no.1, 19-25.
J AOAC Int Noah CW 381 78 1995 10.1093/jaoac/78.2.381
Bavari, S., Pless, Dorothy D., Torres, Edna R., Lebeda, Frank J., Olson, Mark A.. Identifying the principal protective antigenic determinants of type A botulinum neurotoxin. Vaccine, vol.16, no.19, 1850-1856.
Clayton, Jennifer, Middlebrook, John L.. Vaccination of mice with DNA encoding a large fragment of botulinum neurotoxin serotype A. Vaccine, vol.18, no.17, 1855-1862.
Nowakowski, A., Wang, C., Powers, D. B., Amersdorfer, P., Smith, T. J., Montgomery, V. A., Sheridan, R., Blake, R., Smith, L. A., Marks, J. D.. Potent neutralization of botulinum neurotoxin by recombinant oligoclonal antibody. Proceedings of the National Academy of Sciences of the United States of America, vol.99, no.17, 11346-11350.
Clements, J. D., Mullaney, B. P., Pallavicini, M. G., Marks, J. D.. Epitope Mapping of Neutralizing Botulinum Neurotoxin A Antibodies by Phage Display. Infection and immunity, vol.69, no.10, 6511-6514.
Maddaloni, Massimo, Cooke, Corrie, Wilkinson, Royce, Stout, Audrey V., Eng, Leta, Pincus, Seth H.. Immunological Characteristics Associated with the Protective Efficacy of Antibodies to Ricin. The journal of immunology : official journal of the American Association of Immunologists, vol.172, no.10, 6221-6228.
10.1002/(SICI)1099-1263(199912)19:1+<S35::AID-JAT612>3.0.CO;2-9
Chung, Tae‐Wook, Moon, Sung‐Kwon, Chang, Young‐Chae, Ko, Jeong‐Heon, Lee, Young‐Choon, Cho, Gun, Kim, Soo‐Hyun, Kim, Jong‐Guk, Kim, Cheorl‐Ho. Novel and therapeutic effect of caffeic acid and caffeic acid phenyl ester on hepatocarcinoma cells: complete regression of hepatoma growth and metastasis by dual mechanism. The FASEB journal : official publication of the Federation of American Societies for Experimental Biology, vol.18, no.14, 1670-1681.
J Immunol Hirabayashi Y 1218 155 1995 10.4049/jimmunol.155.3.1218
Kwon, Myung-Hee, Lee, Myung-Shin, Kim, Kyongmin, Park, Sun, Shin, Ho-Joon, Jang, Young-Ju, Kim, Hyung-Il. PRODUCTION AND CHARACTERIZATION OF AN ANTI-IDIOTYPIC SINGLE CHAIN FV THAT RECOGNIZES AN ANTI-DNA ANTIBODY. Immunological investigations, vol.31, no.3, 205-218.
J Immunol Brigido MM 469 150 1993 10.4049/jimmunol.150.2.469
Torii, Yasushi, Tokumaru, Yoichi, Kawaguchi, Seijirou, Izumi, Nanae, Maruyama, Seika, Mukamoto, Masafumi, Kozaki, Shunji, Takahashi, Motohide. Production and immunogenic efficacy of botulinum tetravalent (A, B, E, F) toxoid. Vaccine, vol.20, no.19, 2556-2561.
van der Merwe, P. Anton, Barclay, A. Neil, Mason, Don W., Davies, Elizabeth A., Morgan, B. Paul, Tone, Masahide, Krishnam, Ammu K. C., Ianelli, Chris, Davis, Simon J.. Human Cell-Adhesion Molecule CD2 Binds CD58 (LFA-3) with a Very Low Affinity and an Extremely Fast Dissociation Rate but Does Not Bind CD48 or CD59. Biochemistry, vol.33, no.33, 10149-10160.
Dong, Min, Richards, David A., Goodnough, Michael C., Tepp, William H., Johnson, Eric A., Chapman, Edwin R.. Synaptotagmins I and II mediate entry of botulinum neurotoxin B into cells. The Journal of cell biology, vol.162, no.7, 1293-1303.
Blood Montero-Julian FA 917 85 1995 10.1182/blood.V85.4.917.bloodjournal854917
Koriazova, Lilia K., Montal, Mauricio. Translocation of botulinum neurotoxin light chain protease through the heavy chain channel. Nature structural biology, vol.10, no.1, 13-18.
해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.